Extended coverage expands access to iTind for BPH-related LUTS
iTind is a temporary nitinol device used to treat lower urinary tract symptoms caused by benign prostatic hyperplasia.
iTind is a temporary nitinol device used to treat lower urinary tract symptoms caused by benign prostatic hyperplasia.
Designed to foster a spirit of competition and Section pride, the AUA Residents Bowl is the not-to-be-missed event of AUA2024! Each of the eight AUA…
The OFFICIAL site of the American Urological Association’s 2024 Annual Meeting, May 3 – May 6, 2024 in San Antonio, TX. AUA2024 explores the latest…
These skills trainings combine didactic lectures and hands-on sessions instructed by highly accomplished and experienced Faculty. The HOSTs are among the most popular educational offerings…
The OFFICIAL site of the American Urological Association’s 2024 Annual Meeting, May 3 – May 6, 2024 in San Antonio, TX. AUA2024 explores the latest…
What a month of urology excitement April has been! It was wonderful to see over 10,000 urologists join us in Paris at EAU24. All with…
“This clinical study has the potential to demonstrate the value of Chimeric Antigen Receptor (CAR) T cell therapy in solid cancers such as kidney cancer…
Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC Part of an Independent Medical Education Initiative Supported by LOXO@Lilly Biographies:…
The approval was based on data from three phase 3 trials which compared the efficacy of different dosing regimens of pivmecillinam to placebo, to another…
Researchers conducted a systematic review and meta-analysis to assess the relationship between GLP-1RA treatment and blood pressure effects.
“It’s a system that is still not being used to its maximum capability, which is exciting. That means we can continue evolving,” says Jaschar Shakuri-Rad,…